HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
https://doi.org/10.22625/2072-6732-2014-6-2-83-86
Abstract
Presented clinical case describes elimination followed by seroconversion HBsAg / HBsAb patient with HBeAg-negative chronic hepatitis B on antiviral therapy with pegylated interferon α2-a and achieving sustained virological response.
About the Authors
K. V. Zhdanov
Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
D. A. Gusev
Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
K. V. Kozlov
Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
S. S. Zhabrov
Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
A. V. Shekurov
Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
A. V. Nagovitsyn
Branch number 1 Main Military Clinical Hospital named after acad. N.N. Burdenko, Moscow, Russia
Russian Federation
Russian Federation
A. V. Mishin
Branch number 1 Main Military Clinical Hospital named after acad. N.N. Burdenko, Moscow, Russia
Russian Federation
Russian Federation
E. V. Jakovleva
Branch number 1 Main Military Clinical Hospital named after acad. N.N. Burdenko, Moscow, Russia
Russian Federation
Russian Federation
References
1. Marcellin P., Bonino F., Lau G.K. et al. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. Gastroenterology. 2009 Jun; 136(7):2169-2179
2. Zhdanov K.V., Gusev D.A. Infekcionnye bolezni 2013; 11(4): 3 – 10.
3. Zhdanov K.V., Lobzyn Yu.V., Gusev D.A., Kozlov K.V. Viral hepatitis. Saint-Petrsburg; 2011 (in Russian).
4. Zhdanov K.V, Kozlov K.V., Sukachev V.S. Zhurnal infektologii 2009; 1(4):23 – 35.
5. Rajendra A., Wong J.B. Economics of chronic hepatitis B and hepatitis C. J Hepatol. 2007 Oct; 47(4):608-617.
Review
For citations:
Zhdanov K.V., Gusev D.A., Kozlov K.V., Zhabrov S.S., Shekurov A.V., Nagovitsyn A.V., Mishin A.V., Jakovleva E.V. HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy. Journal Infectology. 2014;6(2):83-86. (In Russ.) https://doi.org/10.22625/2072-6732-2014-6-2-83-86
Views:
711
.png)
.png)
Email this article 